DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Auro Impex & Chemicals Limited — Board Meeting Intimation

NSE 30 min ago·7 Nov 2026, 10:28 am

Auro Impex & Chemicals

Auro Impex & Chemicals Limited has announced that its board will meet on November 12, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year.

This interim update provides investors with an early look at the company's performance and financial health, offering a chance to assess its operational progress before the final annual results are released.

Investors should watch for details on revenue growth, profitability, and any changes in the company's debt or cash position during this period.